These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7815477)

  • 1. Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins.
    Dragic T; Picard L; Alizon M
    J Virol; 1995 Feb; 69(2):1013-8. PubMed ID: 7815477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
    Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
    J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.
    Litwin V; Nagashima KA; Ryder AM; Chang CH; Carver JM; Olson WC; Alizon M; Hasel KW; Maddon PJ; Allaway GP
    J Virol; 1996 Sep; 70(9):6437-41. PubMed ID: 8709277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.
    Alkhatib G; Broder CC; Berger EA
    J Virol; 1996 Aug; 70(8):5487-94. PubMed ID: 8764060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection.
    Freed EO; Martin MA
    J Biol Chem; 1995 Oct; 270(41):23883-6. PubMed ID: 7592573
    [No Abstract]   [Full Text] [Related]  

  • 6. Postbinding fusion function contributed by a chimeric murine leukemia virus envelope protein.
    Nakamura H; Takeda A; Matano T
    Arch Virol; 2001; 146(5):953-61. PubMed ID: 11448032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.
    Puri A; Hug P; Jernigan K; Barchi J; Kim HY; Hamilton J; Wiels J; Murray GJ; Brady RO; Blumenthal R
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14435-40. PubMed ID: 9826718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3).
    Hammache D; Yahi N; Maresca M; Piéroni G; Fantini J
    J Virol; 1999 Jun; 73(6):5244-8. PubMed ID: 10233996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
    Finnegan CM; Berg W; Lewis GK; DeVico AL
    J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-1 envelope glycoproteins.
    Puri A; Morris SJ; Jones P; Ryan M; Blumenthal R
    Virology; 1996 May; 219(1):262-7. PubMed ID: 8623537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons.
    Dragic T; Charneau P; Clavel F; Alizon M
    J Virol; 1992 Aug; 66(8):4794-802. PubMed ID: 1629956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus Env-independent infection of human CD4(-) cells.
    Pang S; Yu D; An DS; Baldwin GC; Xie Y; Poon B; Chow YH; Park NH; Chen IS
    J Virol; 2000 Dec; 74(23):10994-1000. PubMed ID: 11069994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
    Alkhatib G; Combadiere C; Broder CC; Feng Y; Kennedy PE; Murphy PM; Berger EA
    Science; 1996 Jun; 272(5270):1955-8. PubMed ID: 8658171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
    J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human erythrocyte glycolipids promote HIV-1 envelope glycoprotein-mediated fusion of CD4+ cells.
    Puri A; Hug P; Muñoz-Barroso I; Blumenthal R
    Biochem Biophys Res Commun; 1998 Jan; 242(1):219-25. PubMed ID: 9439639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2.
    Dragic T; Alizon M
    J Virol; 1993 Apr; 67(4):2355-9. PubMed ID: 8095307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1.
    Moriuchi H; Moriuchi M; Arthos J; Hoxie J; Fauci AS
    J Virol; 1997 Dec; 71(12):9664-71. PubMed ID: 9371631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner.
    Lama J; Mangasarian A; Trono D
    Curr Biol; 1999 Jun; 9(12):622-31. PubMed ID: 10375528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.